Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCity Lon Inv Regulatory News (CLIG)

Share Price Information for City Lon Inv (CLIG)

Share Price is delayed by 15 minutes
Get Live Data
458.00    0.00 (0.00%)
Bid:
0.00
Ask:
459.00
Spread: 13.00 (2.915%)
Market Cap: £226.13m
CLIG Live PriceLast checked at - London Stock Exchange

Intraday City Lon Inv Share Chart

Trading Update

15 Jul 2015 07:00

RNS Number : 0664T
City of London Investment Group PLC
15 July 2015
 

 

City of London Investment Group PLC

15 July 2015



CITY OF LONDON INVESTMENT GROUP PLC

("City of London" or "the Group")

 

TRADING UPDATE

 

for the year to 30 June 2015

 

City of London (LSE: CLIG), a leading emerging markets asset management group, provides a trading update for its financial year ended 30 June 2015. The numbers that follow are all unaudited.

 

Funds under management were US$4.2 billion (£2.7 billion) at 30 June 2015 (2014: US$3.9 billion or £2.3 billion), representing an 8% increase in US$ terms and a 17% increase in GBP terms as a result of the cross rate moving from 1.71 to 1.57 over the period. Over the same period the MSCI Emerging Markets Index (MXEF) fell by 5% in US$ terms.

 

For the year to 30 June 2015, City of London expects that pre-tax profits will be approximately £8.8 million (2014: £7.2 million, 13 months), and that profits after an anticipated tax charge of £2.3 million (26% of pre-tax profits) will be approximately £6.5 million (2014: profits of £5.2 million after a tax charge of £2.0 million, representing 28% of pre-tax profit). Basic and fully diluted earnings per share are expected to be 26.1p and 25.7p respectively (2014: 20.7p and 20.6p).

 

The Board is recommending a final dividend of 16p per share (2014: 16p). This would bring the total for the year to 30 June 2015 to 24p (2014: 24p), making cover 1.1 times earnings per share (2014: 0.86 times). As previously announced the Board's dividend policy is based around a cover of 1.2 times earnings on a rolling five year average. The proposed dividend is in-line with this policy.

 

Overheads for the year to 30 June 2015 are expected to be £9.4 million (2014: £10.3 million, 13 months) and the current monthly run-rate is slightly in excess of £0.8m.

 

Investment performance in the emerging markets closed-end fund (CEF) strategy remains strong, with first or second quartile results versus manager peers year to date in 2015. The present wide size-weighted average discount (SWAD) of c12-13% across client portfolios indicates value in the strategy. The investment approach adds value beyond this by exploiting volatility of the underlying discounts in the CEF universe, from which portfolios are constructed with their specific SWAD characteristics.

 

During the period, marketing efforts led to new inflows of $477 million in emerging market strategies, which were countered by outflows of $437 million as investor risk aversion rose due to ongoing volatility in global markets. Fundraising in the diversification products resulted in $255m of new mandates ($100m in Frontier Emerging Markets strategies, and $155m in Global Tactical Asset Allocation strategies) and outflows of $20 million.

 

As noted in the interim statement these wins will assist with efforts to raise the profile of our diversification CEF products with institutional consultants and plan sponsors. Diversification products now represent 8.5% of Group AUM, compared with 2% last year.

 

City of London Investment Group expects to announce final results along with the Accounts for the year to 30 June 2015 on 14 September 2015. The Company's Annual General Meeting date, and final dividend payment dates are expected to be 19 October 2015 and 30 October 2015 respectively. An Investor Day will be held after the Annual General Meeting on 19 October 2015. Details will be included within the Accounts.

 

As a result of increased volatility, Shareholders will see in the Template below that we have reduced our assumptions regarding net new money from mandates next year to $250 million for the emerging market strategy and an additional $250 million in diversification products. Subsequent to the year end, we are aware of new mandates of circa $35 million with deminimis redemptions. As a result of recent volatility we are reviewing our budget for 2015/2016; as shareholders would expect we will be monitoring costs closely as the year progresses. We will continue to update our web site www.citlon.co.uk for the most recent FUM on a monthly basis.

 

Please note that going forward we will not include an estimate for market growth within the Template.

 

Summary and unaudited trading update

Year to

30 June

2015

13 months

to 30 June

2014

 

Funds under Management (at period end)

US$4.2bn

US$3.9bn

 

Turnover (plus investment income)

£25.4m

£24.4m

 

Administrative expenses, commission payable, and profit-share

£16.6m

£17.2m

 

Profit before tax

£8.8m

£7.2m

 

Profit after tax

£6.5m

£5.2m

 

Profit per share, basic

26.1p

20.7p

 

Profit per share, diluted

25.7p

20.6p

 

 

Financials - consolidated income statement

 

 

£'000

Year to

30 June

2015

13 months

to 30 June

2014

 

Fee income

25,356

24,215

 

Interest & other

65

244

 

Commissions payable

(2,275)

(3,068)

 

Custody & Administration

(738)

(845)

 

Total net income

22,408

20,546

 

Costs:

Human resources

6,250

6,559

 

Premises

634

671

 

Communications & IT

1,376

1,464

 

Business development

499

529

 

General

686

1,075

 

Total costs

9,445

10,298

 

Operating profit

12,963

10,248

 

Profit-share

4,171

3,005

 

Pre-tax profit

8,792

7,243

 

Tax

(2,302)

(2,043)

 

Post-tax profit

6,490

5,200

 

Dividends (prior year final plus current period interim)

(5,960)

(6,031)

 

Retained/(Used)

530

(831)

 

 

 

Template

 

Please see the attached graph which is based on the following assumptions and includes the estimated cost of a maintained dividend:

 

http://www.rns-pdf.londonstockexchange.com/rns/0664T_1-2015-7-14.pdf 

 

Assumptions:

- Starting point Current FuM (end June 2015)

- Net new money in 2015/2016 (straight-lined to June 2016):

emerging market strategies $250m

diversification strategies $250m

- Operating margin adjusted monthly for change in product mix and commission run-off

- Market growth: 0%

- Increase in overhead: 8%

- Corporation tax based on an estimated average rate of 25%

- Exchange rate assumed to be £1/$1.55 for entire period

- Number of CLIG Shares in issue (27.0m) less those held by the ESOP Trust (2.0m) as at 30 June 2015

 

This can also be found on our website at: http://www.citlon.co.uk/shareholders/announcements.php

 

 

For further information, please visit http://www.citlon.co.uk/ or contact:

 

Barry Olliff, CEO

City of London Investment Group PLC

Tel: 001 215 313 3774

 

Martin R Green

Canaccord Genuity Limited

Financial Adviser & Broker

Tel: +44 (0)20 7523 8000

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTSFMEELFISEEW
Date   Source Headline
25th Apr 20237:00 amRNSTrading update
14th Apr 20231:15 pmEQSHardman & Co Q&A on City of London Investment Group (CLIG): Continuing its good performance
4th Apr 20235:10 pmRNSHolding(s) in Company
31st Mar 20239:35 amRNSHolding(s) in Company
27th Mar 20234:40 pmRNSHolding(s) in Company
22nd Mar 20232:30 pmEQSHardman & Co Research on City Of London Investment Group (CLIG): Solid results in volatile markets
21st Mar 20236:04 pmRNSHolding(s) in Company
17th Mar 20235:20 pmRNSHolding(s) in Company
17th Mar 20232:15 pmRNSINTERIM DIVIDEND – US DOLLAR CONVERSION RATE
22nd Feb 20237:00 amRNSHALF YEAR RESULTS TO 31ST DECEMBER 2022
25th Jan 20238:45 amEQSHardman & Co Research on City of London Investment Group: Swings and roundabouts
20th Jan 20237:00 amRNSSIX MONTH TRADING UPDATE AND DIVIDEND DECLARATION
16th Dec 20224:40 pmRNSSecond Price Monitoring Extn
16th Dec 20224:35 pmRNSPrice Monitoring Extension
15th Nov 20223:15 pmEQSHardman & Co Research on City Of London Investment Group: (CLIG) Solid profits in tough markets
31st Oct 20224:22 pmRNSResult of AGM
28th Oct 20225:02 pmRNSHolding(s) in Company
27th Oct 20223:17 pmRNSDirector/PDMR Shareholding
27th Oct 20223:17 pmRNSDirector/PDMR Shareholding
27th Oct 20223:15 pmRNSDirector/PDMR Shareholding
27th Oct 20223:13 pmRNSDirector/PDMR Shareholding
27th Oct 20223:12 pmRNSDirector/PDMR Shareholding
21st Oct 202211:04 amRNSFinal Dividend - US Dollar Conversion Rate
17th Oct 20227:00 amRNSFunds Under Management - 30/09/22 - Trading Update
30th Sep 20222:28 pmRNSHolding(s) in Company
20th Sep 20227:00 amRNSFinal Results
16th Sep 20224:35 pmRNSPrice Monitoring Extension
8th Aug 20227:00 amRNSHolding(s) in Company
28th Jul 20227:15 amEQSHardman & Co Research: City of London Investment Group (CLIG): Robust profits in tough markets
28th Jul 20227:00 amRNSHolding(s) in Company
19th Jul 20227:00 amRNSPRE-CLOSE TRADING UPDATE for year to 30 June 2022
27th Jun 202211:00 amRNSDirector/PDMR Shareholding
17th Jun 20224:41 pmRNSSecond Price Monitoring Extn
17th Jun 20224:37 pmRNSPrice Monitoring Extension
16th May 20225:27 pmRNSHolding(s) in Company
28th Apr 202212:25 pmEQSHardman & Co Research: City of London Investment Group (CLIG) Fighting the market invasion
26th Apr 20227:00 amRNSBoard Restructure and Director retirement
26th Apr 20227:00 amRNSFunds Under Management - 31/3/22 - Trading Update
5th Apr 20224:41 pmRNSSecond Price Monitoring Extn
5th Apr 20224:36 pmRNSPrice Monitoring Extension
9th Mar 20227:00 amRNSDirector/PDMR Shareholding
23rd Feb 20226:19 pmRNSDirector/PDMR Shareholding
23rd Feb 20223:35 pmEQSHardman & Co Research: City of London Investment Group (CLIG) Confirming an excellent first half
18th Feb 20227:00 amRNSHALF YEAR RESULTS TO 31ST DECEMBER 2021
1st Feb 202211:10 amEQSHardman & Co Research: CyanConnode (CYAN) - 3Q22 update: smart meter showtime in India
20th Jan 20224:21 pmEQSHardman & Co Research: City of London Investment Group (CLIG) - You're so special!
19th Jan 20227:00 amRNSFuM 31/12/21, Trading, Dividend & Special Dividend
29th Dec 20214:36 pmRNSPrice Monitoring Extension
6th Dec 20211:34 pmRNSDirector/PDMR Shareholding
3rd Dec 202112:18 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.